Abstract
Brentuximab vedotin (Adcetris) is a cysteine-linked antibody-drug conjugate (ADC) used in the treatment of Hodgkin lymphoma (HL) and systemic anaplast......
小提示:本篇文献需要登录阅读全文,点击跳转登录